Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- TIVO-1Independent statistical analysis of A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TK008Independent statistical analysis of Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TK112690Independent statistical analysis of Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TKAIndependent statistical analysis of Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TL011 in Severe, Active Rheumatoid Arthritis Patients: Complete Statistical AnalysisIndependent statistical analysis of TL011 in Severe, Active Rheumatoid Arthritis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01123070).
- TLCIndependent statistical analysis of Treatment With Lorcaserin for Cocaine Use: The TLC Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03192995).
- TMC114IFD3001 – Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV: Complete Statistical AnalysisIndependent statistical analysis of TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company…
- TMC278LAIndependent statistical analysis of Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TMDPACTIndependent statistical analysis of Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03036215).
- TMH PilotIndependent statistical analysis of Family Telemental Health Intervention for Veterans With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03116464).
- TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA): Complete Statistical AnalysisIndependent statistical analysis of TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TMS in Aphasia Recovery: Complete Statistical AnalysisIndependent statistical analysis of TMS in Aphasia Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04777214).
- TMS_AUD+mTBIIndependent statistical analysis of Pilot rTMS for AUD+mTBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03995173).
- TMS4SIIndependent statistical analysis of TMS for Suicidal Crisis in Active Duty SMs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03014362).
- TMScogModIndependent statistical analysis of Theta Burst Transcranial Magnetic Stimulation of Fronto-parietal Networks: Modulation by Mental State: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TMSIIndependent statistical analysis of Transcranial Magnetic Stimulation for Treatment of Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02196025).
- TMSOCDIndependent statistical analysis of Transcranial Magnetic Stimulation (TMS) in Obsessive Compulsive Disorder (OCD): Mechanisms and Biomarkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166435).
- TN-22Independent statistical analysis of Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03428945).
- TN05Independent statistical analysis of Rituximab in New Onset Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00279305).
- TN07Independent statistical analysis of Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TNBCIndependent statistical analysis of Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TNT-RASPIndependent statistical analysis of Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02832115).
- To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.: Complete Statistical AnalysisIndependent statistical analysis of To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.: primary endpoint results, effect estimate with confidence interval,…
- To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: Complete Statistical AnalysisIndependent statistical analysis of To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: primary endpoint…
- To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.: Complete Statistical AnalysisIndependent statistical analysis of To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT): Complete Statistical AnalysisIndependent statistical analysis of To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.: Complete Statistical AnalysisIndependent statistical analysis of To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered…
- To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Compare Free Gingival Grafts and Connective Tissue Grafts Around Implants With Lack of Keratinized Mucosa: Complete Statistical AnalysisIndependent statistical analysis of To Compare Free Gingival Grafts and Connective Tissue Grafts Around Implants With Lack of Keratinized Mucosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- To Compare Safety and Efficacy of Perrigo’s Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with confidence interval,…
- To Compare Safety and Efficacy of Perrigo’s Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with…
- To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel: Complete Statistical AnalysisIndependent statistical analysis of To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel: primary endpoint results, effect estimate with confidence interval,…
- To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Compare the Safety and Efficacy of Perrigo’s Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions: Complete Statistical AnalysisIndependent statistical analysis of To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions: primary endpoint results, effect estimate…
- To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet: Complete Statistical AnalysisIndependent statistical analysis of To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Evaluate if the Medication Gabapentin Lessens Vulvar Pain: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate if the Medication Gabapentin Lessens Vulvar Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00390013).